Castration Resistant Prostatic Neoplasms Withdrawn Phase 2 Trials for Abiraterone (DB05812)
Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant
| Indication | Status | Phase |
|---|---|---|
| DBCOND0129140 (Castration Resistant Prostatic Neoplasms) | Withdrawn | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03173859 | Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients | Treatment |